고운 김
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
고운 김 has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- 정희 유
질병관리청 감염병정책국 에이즈관리
4 shared publications 정희 현
질병관리청 감염병정책국 에이즈관리
3 shared publications- Taeyoung Kim
Division of HIV/AIDS Prevention, Korea Disease Control and Prevention Agency, Cheongju, Korea, Cheongju, Korea
2 shared publications - Yoonhee Jung
Division of HIV/AIDS Prevention, Korea Disease Control and Prevention Agency, Cheongju, Korea, Cheongju, Korea
2 shared publications - 상식 조
질병관리청 감염병정책국 에이즈관리
2 shared publications - Eonjoo Park
Division of Infectious Disease Response, Capital Regional Center for Disease Control and Prevention, Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 21 August 2026
- Published by Korea Disease Control and Prevention Agency (Public Health Weekly Report)
- Vol. 19 (35) , 1484-1499
2021–2025년 HIV/AIDS 국내 신고 현황 및 추이
김고운, 김은영, 현정희, 유정희. Public Health Weekly Report 2026;19:1484-99. https://doi.org/10.56786/PHWR.2026.19.35.2
- 21 August 2026
- Published by Korea Disease Control and Prevention Agency (Public Health Weekly Report)
- Vol. 19 (35) , 1484-1499
Open Access2021–2025년 HIV/AIDS 국내 신고 현황 및 추이
김고운, 김은영, 현정희, 유정희. Public Health Weekly Report 2026;19:1484-99. https://doi.org/10.56786/PHWR.2026.19.35.2
- Open Access
- 1 December 2025
- Published by Korea Disease Control and Prevention Agency (Public Health Weekly Report) in Public Health Weekly Report
- Vol. 18 (50) , 6-22
2023년 HIV/AIDS 발생과 진료 현황 및 사망통계
김고운, 조상식, 현정희, 유정희*. Public Health Weekly Report 2025;18:6-22. https://doi.org/10.56786/PHWR.2025.18.50suppl.2
- 1 December 2025
- Published by Korea Disease Control and Prevention Agency (Public Health Weekly Report) in Public Health Weekly Report
- Vol. 18 (50) , 6-22
Open Access2023년 HIV/AIDS 발생과 진료 현황 및 사망통계
김고운, 조상식, 현정희, 유정희*. Public Health Weekly Report 2025;18:6-22. https://doi.org/10.56786/PHWR.2025.18.50suppl.2
- Open Access
- 29 October 2025
- Published by Korea Disease Control and Prevention Agency (Public Health Weekly Report) in Public Health Weekly Report
- Vol. 18 (50) , 98-111
에이즈지원시스템의 구축 역사 및 현황
조상식, 김고운, 한소희, 현정희, 유정희*. Public Health Weekly Report 2025;18:98-111. https://doi.org/10.56786/PHWR.2025.18.50suppl.7
- 29 October 2025
- Published by Korea Disease Control and Prevention Agency (Public Health Weekly Report) in Public Health Weekly Report
- Vol. 18 (50) , 98-111
Open Access에이즈지원시스템의 구축 역사 및 현황
조상식, 김고운, 한소희, 현정희, 유정희*. Public Health Weekly Report 2025;18:98-111. https://doi.org/10.56786/PHWR.2025.18.50suppl.7
- Open Access
- 9 May 2025
- Published by Korea Disease Control and Prevention Agency (Public Health Weekly Report) in Public Health Weekly Report
- Vol. 18 (22) , 814-829
2023년 외국인 HIV/AIDS 신고현황
김고운, 김성남, 김태영, 유정희. Public Health Weekly Report 2025;18:814-29. https://doi.org/10.56786/PHWR.2025.18.22.2
- 9 May 2025
- Published by Korea Disease Control and Prevention Agency (Public Health Weekly Report) in Public Health Weekly Report
- Vol. 18 (22) , 814-829
Open Access2023년 외국인 HIV/AIDS 신고현황
김고운, 김성남, 김태영, 유정희. Public Health Weekly Report 2025;18:814-29. https://doi.org/10.56786/PHWR.2025.18.22.2
- Open Access
- 2 January 2025
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 47, e2025002
Cohort profile: a nationwide retrospective cohort of mortality in people living with HIV in Korea, 1985-2020
The increasing number of people living with human immunodeficiency virus (HIV) in Korea has prompted interest in using the national surveillance system as a database for studying their health. To investigate the relationships between socio-demographic and epidemiological characteristics and mortality rates, a nationwide retrospective cohort was formed by integrating surveillance data with the Cause of Death Statistics from Statistics Korea. This integration included incidence reports, epidemiological investigations, and death reports from the surveillance data, enriched with detailed mortality information from the Cause of Death data. The cohort comprised 17,199 adult Korean individuals diagnosed with HIV infection from 1985 to 2020. By the end of 2020, 2,721 of these individuals were confirmed deceased. The sex ratio of the study participants was 14.3:1.0 (male to female), with 78.2% being under 50 years old at the time of diagnosis. Sexual contact was identified as the primary transmission route, accounting for 75.7% of cases. HIV disease emerged as the predominant cause of death, representing two-thirds (1,817 of 2,721) of the fatalities, followed by injuries and trauma, malignancies, and cardiovascular diseases. Recommendations for further cohort studies may be submitted to the Korea Disease Control and Prevention Agency.
- 2 January 2025
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 47, e2025002
Open AccessCohort profile: a nationwide retrospective cohort of mortality in people living with HIV in Korea, 1985-2020
The increasing number of people living with human immunodeficiency virus (HIV) in Korea has prompted interest in using the national surveillance system as a database for studying their health. To investigate the relationships between socio-demographic and epidemiological characteristics and mortality rates, a nationwide retrospective cohort was formed by integrating surveillance data with the Cause of Death Statistics from Statistics Korea. This integration included incidence reports, epidemiological investigations, and death reports from the surveillance data, enriched with detailed mortality information from the Cause of Death data. The cohort comprised 17,199 adult Korean individuals diagnosed with HIV infection from 1985 to 2020. By the end of 2020, 2,721 of these individuals were confirmed deceased. The sex ratio of the study participants was 14.3:1.0 (male to female), with 78.2% being under 50 years old at the time of diagnosis. Sexual contact was identified as the primary transmission route, accounting for 75.7% of cases. HIV disease emerged as the predominant cause of death, representing two-thirds (1,817 of 2,721) of the fatalities, followed by injuries and trauma, malignancies, and cardiovascular diseases. Recommendations for further cohort studies may be submitted to the Korea Disease Control and Prevention Agency.
- Open Access
- 31 August 2024
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 15 (4) , 340-352
Impact of COVID-19 on human immunodeficiency virus tests, new diagnoses, and healthcare visits in the Republic of Korea: a retrospective study from 2016 to 2021
Objectives: Public health workers have been at the forefront of treating patients with coronavirus disease 2019 (COVID-19) and managing the pandemic. The redeployment of this workforce has limited or interrupted other public health services, including testing for human immunodeficiency virus (HIV). This study aims to examine the impact of COVID-19 on HIV testing and diagnosis in the Republic of Korea from 2016 to 2021, comparing data before and after the onset of COVID-19.Methods: Annual HIV testing data were collected from each institution through direct communication or from open-source databases. The annual number of new HIV cases was obtained from the official report of the Korea Disease Control and Prevention Agency. Data on healthcare visits for HIV diagnosis or treatment were extracted from the open-source database of the National Insurance Health Service of Korea. Interrupted time series regression was conducted, stratified by institution type.Results: In 2020, HIV tests, diagnoses, and visits decreased. Notably, public health centers experienced a substantial reduction in 2020−2021 compared to previous years. The annual percentage change in HIV tests was −53.0%, while for HIV diagnoses, it was −31.6%. The decrease in visits for HIV was also most pronounced for public facilities: −33.3% in 2020 and −45.6% in 2021 relative to 2019.Conclusion: The numbers of tests, diagnoses, and healthcare visits for HIV at public health centers in the Republic of Korea substantially decreased in 2020 and 2021. The impacts of these changes on the early diagnosis and treatment of HIV necessitate further monitoring.
- 31 August 2024
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 15 (4) , 340-352
Open AccessImpact of COVID-19 on human immunodeficiency virus tests, new diagnoses, and healthcare visits in the Republic of Korea: a retrospective study from 2016 to 2021
Objectives: Public health workers have been at the forefront of treating patients with coronavirus disease 2019 (COVID-19) and managing the pandemic. The redeployment of this workforce has limited or interrupted other public health services, including testing for human immunodeficiency virus (HIV). This study aims to examine the impact of COVID-19 on HIV testing and diagnosis in the Republic of Korea from 2016 to 2021, comparing data before and after the onset of COVID-19.Methods: Annual HIV testing data were collected from each institution through direct communication or from open-source databases. The annual number of new HIV cases was obtained from the official report of the Korea Disease Control and Prevention Agency. Data on healthcare visits for HIV diagnosis or treatment were extracted from the open-source database of the National Insurance Health Service of Korea. Interrupted time series regression was conducted, stratified by institution type.Results: In 2020, HIV tests, diagnoses, and visits decreased. Notably, public health centers experienced a substantial reduction in 2020−2021 compared to previous years. The annual percentage change in HIV tests was −53.0%, while for HIV diagnoses, it was −31.6%. The decrease in visits for HIV was also most pronounced for public facilities: −33.3% in 2020 and −45.6% in 2021 relative to 2019.Conclusion: The numbers of tests, diagnoses, and healthcare visits for HIV at public health centers in the Republic of Korea substantially decreased in 2020 and 2021. The impacts of these changes on the early diagnosis and treatment of HIV necessitate further monitoring.